Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on delivering therapeutics through effective oral delivery, announced today that it has received revised regulatory guidance for LPCN ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

APAC is expected to grow the fastest in the coming years. The global human microbiome market is projected to grow from $1.07b ...

Colorado's cannabis testing loopholes have led to consumers being deceived about the safety of the products they buy, with ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...

In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Carlos, of Glasgow, struggled for decades with the “constant never-ending ache” of neuropathic pain and episodes of agonising ...

Bushra Sumra’s career highlights the profound impact that expertise in clinical research and regulatory compliance can have ...

Data from the study showed that HEMGENIX continues to deliver sustained factor IX activity levels for up to four years post-treatment. The treatment also provides long-term bleed protection, ...

W. Edwards Deming Quality culture is a cornerstone of any industry, particularly the healthcare industry where patient lives ...